CD8A and neoplasm: However, fewer than 20% of TNBCs achieve durable responses to immune checkpoint inhibitors (5), largely attributed to the immunosuppressive tumor microenvironment (TME) characterized by poor CD8+ T cell infiltration and functional exhaustion (6).